Table 1.
European Neuroendocrine Tumor Society and American Joint Committee on Cancer TNM grading systems for pancreatic tumors[38,39]
ENETS | AJCC | |
T Grade (primary tumor) | ||
Tx | Primary tumor is not assessed | Primary tumor is not assessed |
T0 | No finding of primary tumor | No finding of a primary tumor |
Tis | In situ carcinoma | |
T1 | Tumor is limited to the pancreas and < 2 cm | Tumor is limited to the pancreas and ≤ 2 cm |
T2 | Tumor is limited to the pancreas and 2 to 4 cm | T2 tumor is limited to the pancreas and > 2 cm |
T3 | Tumor is limited to the pancreas and > 4 cm or with positive duodenum or biliary tract invasion | Tumor has progressed beyond the pancreas but there is no celiac or mesenteric artery involvement |
T4 | Tumor has invaded the neighboring organs (stomach, spleen, colon, adrenal gland) or walls of the large vessels (celiac artery or superior mesenteric artery) | Tumor shows celiac or superior mesenteric artery involvement |
N-lymph node status | ||
Nx | Regional lymph nodes are not assessed | Regional lymph nodes are not assessed |
N0 | No regional lymph node metastasis | No regional lymph node metastasis |
N1 | Regional lymph node metastasis is positive | Regional lymph node metastasis is positive |
M-distant metastasis | ||
Mx | Distant metastasis is not assessed | |
M0 | No distant metastasis | No distant metastasis |
M1 | Distant metastasis is positive | Distant metastasis is positive |
Stage | ||
0 | Tis, N0, M0 | |
I | T1, N0, M0 | |
IA | T1, N0, M0 | |
IB | T2, N0, M0 | |
IIA | T2, N0, M0 | T3, N0, M0; T1, N1, M0 |
IIB | T3, N0, M0 | T2, N1, M0; T3,N1,M0 |
III | T4, Any N, M0 | |
IIIA | T4, N0, M0 | |
IIIB | Any T, N1, M0 | |
IV | Any T, Any N, M1 | Any T, Any N, M1 |